Cargando…

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report

Major depressive disorder (MDD) is considered a highly heterogeneous clinical and neurobiological mental disorder. We employed a novel layered treatment design to investigate whether cortical thickness features at baseline differentiated treatment responders from non-responders after 8 and 16 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suh, Jee Su, Minuzzi, Luciano, Raamana, Pradeep Reddy, Davis, Andrew, Hall, Geoffrey B., Harris, Jacqueline, Hassel, Stefanie, Zamyadi, Mojdeh, Arnott, Stephen R., Alders, Gésine L., Sassi, Roberto B., Milev, Roumen, Lam, Raymond W., MacQueen, Glenda M., Strother, Stephen C., Kennedy, Sidney H., Frey, Benicio N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011077/ https://www.ncbi.nlm.nih.gov/pubmed/32036277 http://dx.doi.org/10.1016/j.nicl.2020.102178

Ejemplares similares

Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study
por: Ayyash, Sondos, et al.
Publicado: (2021)

Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants
por: Hassel, Stefanie, et al.
Publicado: (2019)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
por: Ballester, Pedro L., et al.
Publicado: (2021)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
por: Harris, Jacqueline K., et al.
Publicado: (2022)

Multisite Comparison of MRI Defacing Software Across Multiple Cohorts
por: Theyers, Athena E., et al.
Publicado: (2021)

Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach
por: Liang, Shuai, et al.
Publicado: (2021)

A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI
por: Ali, Mohammad, et al.
Publicado: (2022)

Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
por: Yrondi, Antoine, et al.
Publicado: (2021)

Gray matter volume drives the brain age gap in schizophrenia: a SHAP study
por: Ballester, Pedro L., et al.
Publicado: (2023)

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report
por: Caspani, Giorgia, et al.
Publicado: (2021)

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
por: Fiori, Laura M., et al.
Publicado: (2021)

Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
por: Yrondi, Antoine, et al.
Publicado: (2019)

Volumetric MRI Analysis of a Case of Severe Ventriculomegaly
por: Alders, Gésine L., et al.
Publicado: (2018)

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
por: Ju, Chelsey, et al.
Publicado: (2019)

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
por: Lam, Raymond W., et al.
Publicado: (2016)

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Biological rhythms are independently associated with quality of life in bipolar disorder
por: Cudney, Lauren E., et al.
Publicado: (2016)

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
por: Sajjadian, Mehri, et al.
Publicado: (2023)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1
por: Nunez, John-Jose, et al.
Publicado: (2021)

The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
por: Harkness, Kate L., et al.
Publicado: (2023)

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
por: Oluboka, Oloruntoba J, et al.
Publicado: (2017)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
por: Lopez, Juan Pablo, et al.
Publicado: (2017)

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder
por: Brown, Elliot C, et al.
Publicado: (2018)

Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
por: Slyepchenko, Anastasiya, et al.
Publicado: (2021)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
por: Islam, Farhana, et al.
Publicado: (2022)

Youth at-risk for serious mental illness: methods of the PROCAN study
por: Addington, Jean, et al.
Publicado: (2018)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
por: Marshe, Victoria S., et al.
Publicado: (2021)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
por: Lin, Rixing, et al.
Publicado: (2023)

From anatomy to function: the role of the somatosensory cortex in emotional regulation
por: Kropf, Erika, et al.
Publicado: (2018)

The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study
por: Kuhathasan, Nirushi, et al.
Publicado: (2021)

An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample
por: Kuhathasan, Nirushi, et al.
Publicado: (2022)

A postmenopausal woman presenting with Ekbom syndrome associated with recurrent depressive disorder: a case report
por: Mahler, Courtney, et al.
Publicado: (2008)

Psychological Factors in Asthma
por: Van Lieshout, Ryan J, et al.
Publicado: (2008)

The Role of Adipokines in Understanding the Associations between Obesity and Depression
por: Taylor, Valerie H., et al.
Publicado: (2010)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
por: Behr, Guilherme A., et al.
Publicado: (2012)

Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
por: Zhdanov, Andrey, et al.
Publicado: (2020)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
por: Espinola, Caroline W., et al.
Publicado: (2022)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
por: Yatham, Lakshmi N, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5tegm082dtq3c9i07edil9lfnk